OBJECTIVES: The 2014 American Society of Clinical Oncology (ASCO) payment reform proposal includes value-based adjustments based on performance on quality, use of/adherence to pathways, and utilization of other healthcare resources. The objective of this analysis was to assess current use of QOC metrics in US cancer care. METHODS: Medical-oncologists and hematologist/oncologists across the US, practicing for at least 2yrs and managing at least 20 patients, were randomly sampled to participate in a cross-sectional survey via a panel. RESULTS: CONCLUSIONS: Standard QOC metrics for cancer care appear to be underutilized and appear to vary based on an affiliation with an ACO or use of EHR. Impact of observed patterns on patient care delivery/outcomes warrants scrutiny.